Head & Neck Oncology: Carcinoma of the Maxillary Sinus
High-Yield Revision Notes for Board Review & PG Entrance Examinations
Malignant tumors of the paranasal sinuses are relatively rare, accounting for less than 1% of all malignancies and roughly 3% of upper aerodigestive tract cancers. Among these, the maxillary sinus is the most common site affected (accounting for ~80% of cases). Because the sinus is a large, air-filled cavity, these tumors typically remain clinically silent for long periods, presenting at advanced stages (T3 or T4) once they breach the bony walls.
1. Histopathology & Risk Factors
- Predominant Histology: Squamous Cell Carcinoma (SCC) is the most common histological variant, responsible for up to 80% of all cases. Other less common histologies include Adenocarcinoma, Adenoid Cystic Carcinoma (propensity for perineural invasion), and Sinonasal Undifferentiated Carcinoma (SNUC).
- High-Yield Occupational Risk Factors:
- Wood dust exposure (Hardwood): Strongly associated with Adenocarcinoma of the ethmoid and maxillary sinuses.
- Nickel and Chrome refining, Leather dust: Associated with Squamous Cell Carcinoma.
- Thorotrast: Historically used contrast agent, associated with long-term risk of maxillary sinus malignancies.
- Inverted Papilloma: A benign but locally aggressive neoplastic sinonasal lesion that harbors a 5% to 15% rate of synchronous or metachronous transformation into Squamous Cell Carcinoma.
2. Clinical Features based on Direction of Spread
The specific presentation depends on which bony wall of the maxillary antrum the tumor erodes and invades:
| Direction of Spread | Anatomical Structures Invaded | Key Clinical Presentation |
|---|---|---|
| Anterior / Anterolateral | Anterior wall of the maxilla, facial soft tissues, cheek skin | Facial asymmetry, palpable cheek mass, cheek numbness (infraorbital nerve involvement) |
| Medial | Lateral nasal wall, turbinates, nasolacrimal duct | Unilateral nasal obstruction, blood-stained discharge, epistaxis, epiphora (tearing) |
| Inferior | Floor of sinus, hard palate, alveolar ridge, roots of upper molars | Loose upper molars, unhealed tooth extraction socket, palatal ulceration/mass, ill-fitting dentures |
| Superior | Orbital floor, lamina papyracea, periorbita | Proptosis, diplopia (double vision), upward globe displacement, ophthalmoplegia |
| Posterior | Pterygoid plates, infratemporal fossa, pterygopalatine fossa | Trismus (due to spasm/invasion of pterygoid muscles), deep retro-orbital headache, cranial nerve palsies |
3. Key Prognostic Linings: Ohngren’s and Lederman’s Lines
Anatomical lines are utilized to categorize the tumor’s location, predicting its biological behavior, risk of base of skull extension, and overall prognosis.
- Ohngren’s Line (Prognostic): An imaginary line drawn on a sagittal view connecting the medial canthus of the eye to the angle of the mandible. It divides the maxillary sinus into two distinct regions:
- Anteroinferior (Suprastructure): Tumors here carry a better prognosis as they manifest early with dental or facial changes and are technically easier to resect safely.
- Posterosuperior (Infrastructure): Tumors here carry a poorer prognosis. They are close to vital skull base structures, the cribriform plate, orbital apex, and pterygoid plates, making early diagnosis tough and complete surgical clearance difficult.
- Lederman’s Lines (Classification): Two horizontal lines that divide the upper jaw and sinonasal area into three levels (Infrastructure, Mesostructure, and Suprastructure).
- The upper line passes horizontally across the floors of both orbits.
- The lower line passes horizontally across the floors of the maxillary sinuses (hard palate).
4. Staging (AJCC 8th Edition) & Metastatic Patterns
- T1: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone.
- T2: Tumor causing bone erosion or destruction, including extension into the hard palate and/or middle nasal meatus.
- T3: Tumor invades any of the following: posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses.
- T4a (Resectable Advanced): Invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses.
- T4b (Unresectable Advanced): Invades orbital apex, dura, brain, middle cranial fossa, cranial nerves (other than V2), nasopharynx, or clivus.
- Lymphatic Drainage: The maxillary sinus has a sparse capillary lymphatic network. Lymphatic spread occurs late, draining primarily to the submandibular nodes (Level IB) and the upper deep cervical nodes (Level II), as well as the retropharyngeal lymph nodes. Retropharyngeal nodes are often the first tier for posterior-wall tumors.
5. Diagnostic & Management Protocol
Imaging Modalities:
- Contrast-Enhanced CT (CECT): Superb for assessing fine bony details, cortical bone erosion, and defining bony borders.
- MRI: Crucial to differentiate retained sinus secretions/mucus from true tumor tissue, and to evaluate for perineural invasion (along CN V2), orbital apex involvement, or dural invasion.
- Biopsy: Performed transnasally via rigid endoscopy (endoscopic punch biopsy) to confirm histopathology. If the tumor is completely contained within the sinus without expanding medially, an anterior antrostomy (Caldwell-Luc approach) may be required for tissue diagnosis.
- Treatment Strategy:
- Early stage (T1–T2) or resectable advanced disease (T3–T4a) is managed via multimodality therapy: surgical resection followed by postoperative adjuvant radiotherapy or concurrent chemoradiotherapy.
- Surgical approaches range from Partial Maxilectomy (inferior tumors preserving the orbital floor) to Total Maxilectomy (removal of all six walls of the maxilla; requires orbital exenteration if the periorbita or orbital fat is breached). Reconstruction is performed using a dental obturator or free tissue flaps (e.g., fibula free flap).